
Ivan A. Greene
Examiner (ID: 18341, Phone: (571)270-5868 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 712 |
| Issued Applications | 117 |
| Pending Applications | 109 |
| Abandoned Applications | 517 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13618307
[patent_doc_number] => 20180360705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS
[patent_app_type] => utility
[patent_app_number] => 16/061156
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061156 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS | Aug 25, 2016 | Pending |
Array
(
[id] => 13618307
[patent_doc_number] => 20180360705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS
[patent_app_type] => utility
[patent_app_number] => 16/061156
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061156 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS | Aug 25, 2016 | Pending |
Array
(
[id] => 13354381
[patent_doc_number] => 20180228730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => USE OF WATER-SOLUBLE POLYMERS BASED ON N-VINYLPYRROLIDONE AND ACRYLIC ACID AS PHARMACEUTICAL ADJUVANTS
[patent_app_type] => utility
[patent_app_number] => 15/751889
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751889 | USE OF WATER-SOLUBLE POLYMERS BASED ON N-VINYLPYRROLIDONE AND ACRYLIC ACID AS PHARMACEUTICAL ADJUVANTS | Aug 16, 2016 | Abandoned |
Array
(
[id] => 13326051
[patent_doc_number] => 20180214563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => IMMUNOSTIMULATORY NANOCARRIER
[patent_app_type] => utility
[patent_app_number] => 15/748469
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748469 | IMMUNOSTIMULATORY NANOCARRIER | Jul 27, 2016 | Abandoned |
Array
(
[id] => 13326051
[patent_doc_number] => 20180214563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => IMMUNOSTIMULATORY NANOCARRIER
[patent_app_type] => utility
[patent_app_number] => 15/748469
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748469 | IMMUNOSTIMULATORY NANOCARRIER | Jul 27, 2016 | Abandoned |
Array
(
[id] => 13790497
[patent_doc_number] => 20190008787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 15/745190
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745190
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745190 | MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM | Jul 12, 2016 | Abandoned |
Array
(
[id] => 12904870
[patent_doc_number] => 20180193465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => DRUG SUSTAINED-RELEASE CARRIER AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 15/744019
[patent_app_country] => US
[patent_app_date] => 2016-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744019
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744019 | DRUG SUSTAINED-RELEASE CARRIER AND METHOD FOR PRODUCING SAME | Jul 12, 2016 | Abandoned |
Array
(
[id] => 11310109
[patent_doc_number] => 20160346219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/208258
[patent_app_country] => US
[patent_app_date] => 2016-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15300
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/208258 | PHOSPHOLIPID-COATED THERAPEUTIC AGENT NANOPARTICLES AND RELATED METHODS | Jul 11, 2016 | Abandoned |
Array
(
[id] => 13325687
[patent_doc_number] => 20180214381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/749469
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749469 | PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF | Jul 6, 2016 | Abandoned |
Array
(
[id] => 12880456
[patent_doc_number] => 20180185327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/742379
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742379
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742379 | FORMULATION COMPRISING PARTICLES AND A LIPASE INHIBITOR | Jul 6, 2016 | Abandoned |
Array
(
[id] => 11362727
[patent_doc_number] => 20170000709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'EMULSIONS COMPRISING CATIONIC EMULSIFIERS BASED ON MDIPA ESTER QUATS'
[patent_app_type] => utility
[patent_app_number] => 15/201898
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6329
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15201898
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/201898 | Emulsions comprising cationic emulsifiers based on MDIPA ester quats | Jul 4, 2016 | Issued |
Array
(
[id] => 12880942
[patent_doc_number] => 20180185489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => DEPOT PREPARATION CONTAINING CITRIC ACID ESTER
[patent_app_type] => utility
[patent_app_number] => 15/740219
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/740219 | DEPOT PREPARATION CONTAINING CITRIC ACID ESTER | Jun 29, 2016 | Abandoned |
Array
(
[id] => 12857791
[patent_doc_number] => 20180177771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/738090
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738090
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738090 | BIOMARKERS FOR NANOPARTICLE COMPOSITIONS | Jun 28, 2016 | Abandoned |
Array
(
[id] => 11362828
[patent_doc_number] => 20170000809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'ARGININE SILICATE INOSITOL FOR IMPROVING COGNITIVE FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/197269
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11259
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197269
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/197269 | ARGININE SILICATE INOSITOL FOR IMPROVING COGNITIVE FUNCTION | Jun 28, 2016 | Abandoned |
Array
(
[id] => 13489861
[patent_doc_number] => 20180296473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Ophthalmologic Pharmaceutical Composition
[patent_app_type] => utility
[patent_app_number] => 15/737894
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737894
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737894 | Ophthalmologic Pharmaceutical Composition | Jun 23, 2016 | Abandoned |
Array
(
[id] => 15020537
[patent_doc_number] => 20190321273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => USE OF CERTAIN COMPOUNDS TO MODIFY, REDUCE, OR ELIMINATE OFF-NOTES
[patent_app_type] => utility
[patent_app_number] => 16/310289
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16310289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/310289 | USE OF CERTAIN COMPOUNDS TO MODIFY, REDUCE, OR ELIMINATE OFF-NOTES | Jun 20, 2016 | Abandoned |
Array
(
[id] => 12785824
[patent_doc_number] => 20180153777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => POWDER COSMETIC COMPOSITION, USES AND PROCESS FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/576938
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576938 | POWDER COSMETIC COMPOSITION, USES AND PROCESS FOR THE PREPARATION THEREOF | Jun 2, 2016 | Abandoned |
Array
(
[id] => 11310098
[patent_doc_number] => 20160346208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'DUAL RESPONSIVE BRAIN TARGETED NANOPARTICLES AND THEIR APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/164994
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4705
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15164994
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/164994 | DUAL RESPONSIVE BRAIN TARGETED NANOPARTICLES AND THEIR APPLICATIONS | May 25, 2016 | Abandoned |
Array
(
[id] => 12766450
[patent_doc_number] => 20180147318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same
[patent_app_type] => utility
[patent_app_number] => 15/574519
[patent_app_country] => US
[patent_app_date] => 2016-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574519
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574519 | Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same | May 17, 2016 | Abandoned |
Array
(
[id] => 13586213
[patent_doc_number] => 20180344655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => FUNCTIONALIZED POLYMERIC PARTICLES FOR TREATMENT OF GLIOMAS
[patent_app_type] => utility
[patent_app_number] => 15/573809
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573809 | FUNCTIONALIZED POLYMERIC PARTICLES FOR TREATMENT OF GLIOMAS | May 10, 2016 | Abandoned |